Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma

With high mortality and poor prognosis, hepatocellular carcinoma (LIHC) has become the fourth leading cause of cancer-related deaths worldwide. Most of the LIHC patients missed the best treatment period because of the untimely diagnosis. For others, even if they are temporarily cured, they have to f...

Full description

Bibliographic Details
Main Authors: Shan-Shan Jiang, Sheng-Jie Ke, Zun-Li Ke, Juan Li, Xiang Li, Xing-Wei Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.657161/full
_version_ 1819139985490575360
author Shan-Shan Jiang
Sheng-Jie Ke
Zun-Li Ke
Juan Li
Xiang Li
Xing-Wei Xie
author_facet Shan-Shan Jiang
Sheng-Jie Ke
Zun-Li Ke
Juan Li
Xiang Li
Xing-Wei Xie
author_sort Shan-Shan Jiang
collection DOAJ
description With high mortality and poor prognosis, hepatocellular carcinoma (LIHC) has become the fourth leading cause of cancer-related deaths worldwide. Most of the LIHC patients missed the best treatment period because of the untimely diagnosis. For others, even if they are temporarily cured, they have to face a very low prognostic survival rate and a very high risk of recurrence. Based on the characteristics of abnormal proliferation and uncontrolled growth of tumor cells. Cell Division Cycle Associated (CDCA) family genes, which are responsible for regulating the cell cycle and proliferation, were selected as our research object to explore the mechanism of hepatocarcinogenesis. To this end, we investigated the expression profiles of CDCA family genes in LIHC and corresponding normal tissues, and the effect of CDCAs expression on the survival of prognosis and immune cell infiltration through bioinformatics analysis methods and the publicly accessible online databases. In addition, we also analyzed the expression correlation of CDCAs and screened the neighboring genes related to functional CDCAs. The results revealed that the expression levels of CDCA1/3/5/8 were significantly increased in LIHC, regardless of stage, sex, race, drinking behavior, and other clinical factors. CDCAs expression was significantly correlated with poor prognosis and was positively correlated with the infiltration of dendritic cells, B cells, and macrophages. We also found that the most relevant neighboring genes to CDCAs in LIHC were SGO2, NDC80, BIRC5, INCENP, and PLOD1. In general, our work suggests that CDCA1/3/5/8 has the potential to be a diagnostic gene in hepatocarcinogenesis and prognostic biomarkers for LIHC patients.
first_indexed 2024-12-22T11:31:22Z
format Article
id doaj.art-7792c46d516a469586086bb24bcef3f0
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-12-22T11:31:22Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-7792c46d516a469586086bb24bcef3f02022-12-21T18:27:35ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2021-03-01810.3389/fmolb.2021.657161657161Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular CarcinomaShan-Shan Jiang0Sheng-Jie Ke1Zun-Li Ke2Juan Li3Xiang Li4Xing-Wei Xie5Key Laboratory of Forensic Toxicology of Herbal Medicines, Guizhou Education Department, School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, ChinaFaculty of Basic Medicine, Zhengzhou Shuqing Medical College, Henan, ChinaKey Laboratory of Forensic Toxicology of Herbal Medicines, Guizhou Education Department, School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, ChinaKey Laboratory of Forensic Toxicology of Herbal Medicines, Guizhou Education Department, School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, ChinaCollege of Plant Protection, Henan Agricultural University, Zhengzhou, ChinaKey Laboratory of Forensic Toxicology of Herbal Medicines, Guizhou Education Department, School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, ChinaWith high mortality and poor prognosis, hepatocellular carcinoma (LIHC) has become the fourth leading cause of cancer-related deaths worldwide. Most of the LIHC patients missed the best treatment period because of the untimely diagnosis. For others, even if they are temporarily cured, they have to face a very low prognostic survival rate and a very high risk of recurrence. Based on the characteristics of abnormal proliferation and uncontrolled growth of tumor cells. Cell Division Cycle Associated (CDCA) family genes, which are responsible for regulating the cell cycle and proliferation, were selected as our research object to explore the mechanism of hepatocarcinogenesis. To this end, we investigated the expression profiles of CDCA family genes in LIHC and corresponding normal tissues, and the effect of CDCAs expression on the survival of prognosis and immune cell infiltration through bioinformatics analysis methods and the publicly accessible online databases. In addition, we also analyzed the expression correlation of CDCAs and screened the neighboring genes related to functional CDCAs. The results revealed that the expression levels of CDCA1/3/5/8 were significantly increased in LIHC, regardless of stage, sex, race, drinking behavior, and other clinical factors. CDCAs expression was significantly correlated with poor prognosis and was positively correlated with the infiltration of dendritic cells, B cells, and macrophages. We also found that the most relevant neighboring genes to CDCAs in LIHC were SGO2, NDC80, BIRC5, INCENP, and PLOD1. In general, our work suggests that CDCA1/3/5/8 has the potential to be a diagnostic gene in hepatocarcinogenesis and prognostic biomarkers for LIHC patients.https://www.frontiersin.org/articles/10.3389/fmolb.2021.657161/fullCDCAhepatocellular carcinomabiomarkersprognosistumor immunity
spellingShingle Shan-Shan Jiang
Sheng-Jie Ke
Zun-Li Ke
Juan Li
Xiang Li
Xing-Wei Xie
Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
Frontiers in Molecular Biosciences
CDCA
hepatocellular carcinoma
biomarkers
prognosis
tumor immunity
title Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
title_full Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
title_fullStr Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
title_full_unstemmed Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
title_short Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
title_sort cell division cycle associated genes as diagnostic and prognostic biomarkers in hepatocellular carcinoma
topic CDCA
hepatocellular carcinoma
biomarkers
prognosis
tumor immunity
url https://www.frontiersin.org/articles/10.3389/fmolb.2021.657161/full
work_keys_str_mv AT shanshanjiang celldivisioncycleassociatedgenesasdiagnosticandprognosticbiomarkersinhepatocellularcarcinoma
AT shengjieke celldivisioncycleassociatedgenesasdiagnosticandprognosticbiomarkersinhepatocellularcarcinoma
AT zunlike celldivisioncycleassociatedgenesasdiagnosticandprognosticbiomarkersinhepatocellularcarcinoma
AT juanli celldivisioncycleassociatedgenesasdiagnosticandprognosticbiomarkersinhepatocellularcarcinoma
AT xiangli celldivisioncycleassociatedgenesasdiagnosticandprognosticbiomarkersinhepatocellularcarcinoma
AT xingweixie celldivisioncycleassociatedgenesasdiagnosticandprognosticbiomarkersinhepatocellularcarcinoma